₹6.00
Price
Trading Data
range barsReturns
absolute and vs benchmark indexAbout the Company
Vista Pharmaceuticals Ltd, the largest division of Torrent Pharmaceuticals Ltd offers a range of products mainly in the therapeutic areas of gastrointestinal, pain management and anti-infective, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- HQ
- Nalgonda, Telangana
- CEO & MD
- Dhananjaya Alli
- Registrar
- Aarthi Consultants Pvt Ltd
- Exchange
- BSE
- ISIN
- INE427C01021
Institutional Demand
passive ownership through ETFsContext
where this company sitsFrequently Asked
▶What is the share price of Vista Pharmaceuticals Ltd today?
Vista Pharmaceuticals Ltd (VISTAPH) is trading at ₹6. The price shown is the latest available from the exchange feed and updates through the trading session.
▶What is VISTAPH’s P/E ratio versus the sector?
VISTAPH trades at a P/E of —. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.
▶What is VISTAPH’s dividend yield?
VISTAPH has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.
▶What is VISTAPH’s 52-week high and low?
VISTAPH has traded between ₹5.32 and ₹10.1 over the past year. The Trading Data block shows where the current price sits inside that band.
▶What is the market capitalisation of Vista Pharmaceuticals Ltd?
Vista Pharmaceuticals Ltd has a market capitalisation of ₹41 crore.
▶What is VISTAPH’s return on equity?
VISTAPH reports a return on equity of -29.5%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Drug Manufacturers - Specialty & Generic.
▶Who are VISTAPH’s competitors?
The Peers block on this page lists other Drug Manufacturers - Specialty & Generic companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.
▶What is VISTAPH’s promoter holding?
Promoters hold 21.19% of VISTAPH. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.
▶Which indices include VISTAPH?
Index membership is listed in the Context block on this page, along with the weight VISTAPH carries in each. That weight is what determines how much passive money tracks the stock.
▶Is Vista Pharmaceuticals Ltd a good buy?
We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from VISTAPH’s own numbers. The judgement is yours.
VISTAPH at a glance
Vista Pharmaceuticals Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector. Vista Pharmaceuticals Ltd (VISTAPH) last traded at ₹6, giving it a market capitalisation of ₹41 crore. The 52-week range is ₹5.32 to ₹10.1, and the price is 14% of the way up that range. Promoters hold 21.19% of the company in the latest shareholding filing. Among 158 listed companies in the Drug Manufacturers - Specialty & Generic industry, Vista Pharmaceuticals Ltd is 133rd by market capitalisation. The median price-to-earnings ratio across these companies is 30.8. Its return on equity of -16.6% compares with an industry median of 10.7%, ranking 150th of 157 peers reporting it.
| Market cap | ₹41 crore |
|---|---|
| ROE | -29.5% |
| ROCE | -30.3% |